Advanced search
Publication Cover
Oncolytic Virotherapy Volume 2, 2013 - Issue
Journal homepage
182
Views
19
CrossRef citations to date
0
Altmetric
Review

Cell carriers for oncolytic viruses: current challenges and future directions

Dominic G Roy1 Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada;2 Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, ON, Canada
&
John C Bell1 Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada;2 Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, ON, Canada;3 Department of Medicine, University of Ottawa, Ottawa, ON, CanadaCorrespondence[email protected]
Pages 47-56 | Published online: 10 Oct 2013

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Moumita Mondal, Jingao Guo, Ping He & Dongming Zhou. (2020) Recent advances of oncolytic virus in cancer therapy. Human Vaccines & Immunotherapeutics 16:10, pages 2389-2402.
Read now
Lingyang Hua & Hiroaki Wakimoto. (2019) Oncolytic herpes simplex virus therapy for malignant glioma: current approaches to successful clinical application. Expert Opinion on Biological Therapy 19:8, pages 845-854.
Read now
Claudia Hill & Robert Carlisle. (2019) Achieving systemic delivery of oncolytic viruses. Expert Opinion on Drug Delivery 16:6, pages 607-620.
Read now
Laure Aurelian. (2016) Oncolytic viruses as immunotherapy: progress and remaining challenges. OncoTargets and Therapy 9, pages 2627-2637.
Read now

Articles from other publishers (15)

Chenglong Liu, Mengxuan Yang, Daizhou Zhang, Ming Chen & Di Zhu. (2022) Clinical cancer immunotherapy: Current progress and prospects. Frontiers in Immunology 13.
Crossref
Qing Ji, Yuchen Wu, Andreas Albers, Meiyu Fang & Xu Qian. (2022) Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches. Pharmaceutics 14:9, pages 1811.
Crossref
Su Shao, Xue Yang, You-Ni Zhang, Xue-Jun Wang, Ke Li, Ya-Long Zhao, Xiao-Zhou Mou & Pei-Yang Hu. (2022) Oncolytic Virotherapy in Peritoneal Metastasis Gastric Cancer: The Challenges and Achievements. Frontiers in Molecular Biosciences 9.
Crossref
Masmudur M. Rahman & Grant McFadden. (2021) Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy. Cancers 13:21, pages 5452.
Crossref
Jonathan Santos Apolonio, Vinícius Lima de Souza Gonçalves, Maria Luísa Cordeiro Santos, Marcel Silva Luz, João Victor Silva Souza, Samuel Luca Rocha Pinheiro, Wedja Rafaela de Souza, Matheus Sande Loureiro & Fabrício Freire de Melo. (2021) Oncolytic virus therapy in cancer: A current review. World Journal of Virology 10:5, pages 229-255.
Crossref
Ifeanyi Kingsley Uche, Konstantin G. Kousoulas & Paul J. F. Rider. (2021) The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment. Viruses 13:7, pages 1200.
Crossref
Norah Aldrak, Sarah Alsaab, Aliyah Algethami, Deepak Bhere, Hiroaki Wakimoto, Khalid Shah, Mohammad N. Alomary & Nada Zaidan. (2021) Oncolytic Herpes Simplex Virus-Based Therapies for Cancer. Cells 10:6, pages 1541.
Crossref
Olga V. Matveeva & Svetlana A. Shabalina. (2020) Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy. Cancers 12:12, pages 3659.
Crossref
Anjali Lathwal, Rajesh Kumar & Gajendra P.S. Raghava. (2020) Computer-aided designing of oncolytic viruses for overcoming translational challenges of cancer immunotherapy. Drug Discovery Today 25:7, pages 1198-1205.
Crossref
Khaphetsi Joseph Mahasa, Lisette de Pillis, Rachid Ouifki, Amina Eladdadi, Philip Maini, A-Rum Yoon & Chae-Ok Yun. (2020) Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy. Scientific Reports 10:1.
Crossref
Carlos Arturo Guerrero-Fonseca, Miguel Andrés López-Baquero & Angie Andrea Bedoya-Rodríguez. (2019) Virus oncolíticos: un arma contra el cáncer. Revista de la Facultad de Medicina 67:2, pages 331-324.
Crossref
A. O. Sitkovskaya, E. Yu. Zlatnik, I. A. Novikova & O. I. Kit. (2019) Newcastle disease virus - effective alliance in the fight against cancer. Siberian journal of oncology 17:6, pages 105-113.
Crossref
Derek R. Clements, John Patrick Murphy, Andra Sterea, Barry E. Kennedy, Youra Kim, Erin Helson, Shekoufeh Almasi, Namit Holay, Prathyusha Konda, Joao A. Paulo, Tanveer Sharif, Patrick W. Lee, Michael P. Weekes, Steven P. Gygi & Shashi Gujar. (2017) Quantitative Temporal in Vivo Proteomics Deciphers the Transition of Virus-Driven Myeloid Cells into M2 Macrophages. Journal of Proteome Research 16:9, pages 3391-3406.
Crossref
Amelia Aitken, Dominic Roy & Marie-Claude Bourgeois-Daigneault. (2017) Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies. Biomedicines 5:4, pages 3.
Crossref
Theresa Falls, Dominic Guy Roy, John Cameron Bell & Marie-Claude Bourgeois-Daigneault. (2016) Murine Tumor Models for Oncolytic Rhabdo-Virotherapy. ILAR Journal 57:1, pages 73-85.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.